Literature DB >> 29242192

The ubiquitin E3 ligase CHIP promotes proteasomal degradation of the serine/threonine protein kinase PINK1 during staurosporine-induced cell death.

Lang Yoo1, Kwang Chul Chung2.   

Abstract

Mutations in the gene for the serine/threonine protein kinase PTEN-induced putative kinase 1 (PINK1) are the second most frequent cause of autosomal recessive Parkinson's disease (PD). Via its kinase activity, PINK1 regulates neuronal cell survival and mitochondrial quality control. Numerous reports have revealed that PINK1 has diverse and physiologically significant functions, and therefore its activity should be tightly regulated. However, the molecular mechanisms regulating PINK1 stability and the modulator(s) involved have not been elucidated. In this study, we demonstrate that the ubiquitin E3 ligase carboxyl terminus of Hsp70-interacting protein (CHIP) promotes PINK1 ubiquitination and decreases its steady-state levels. Moreover, PINK1 levels were strongly reduced in HEK293 and SH-SY5Y cells exposed to the apoptosis-inducer staurosporine. Of note, we found that this reduction resulted from CHIP-mediated PINK1 ubiquitination. Accordingly, siRNA-mediated CHIP knockdown reduced susceptibility to staurosporine-induced cell death. Taken together, these findings suggest that CHIP plays a role in negative regulation of PINK1 stability and may suppress PINK1's cytoprotective effect during staurosporine-induced mammalian cell death. We propose that this PINK1 regulatory pathway might contribute to Parkinson's disease pathogenesis.
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  70 kilodalton heat shock protein (Hsp70); CHIP; E3 ubiquitin ligase; Hsp70; PTEN-induced putative kinase 1 (PINK1); cell death; staurosporine; ubiquitination; ubiquitylation

Mesh:

Substances:

Year:  2017        PMID: 29242192      PMCID: PMC5787805          DOI: 10.1074/jbc.M117.803890

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

Review 1.  Proteolytic control of mitochondrial function and morphogenesis.

Authors:  Ruchika Anand; Thomas Langer; Michael James Baker
Journal:  Biochim Biophys Acta       Date:  2012-06-27

2.  Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP.

Authors:  M Emdadul Haque; Kelly J Thomas; Cheryl D'Souza; Steve Callaghan; Tohru Kitada; Ruth S Slack; Paul Fraser; Mark R Cookson; Anurag Tandon; David S Park
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-24       Impact factor: 11.205

3.  The BAG2 protein stabilises PINK1 by decreasing its ubiquitination.

Authors:  Xiangqian Che; Beisha Tang; Xuejing Wang; Dong Chen; Xinxiang Yan; Hong Jiang; Lu Shen; Qian Xu; Guanghui Wang; Jifeng Guo
Journal:  Biochem Biophys Res Commun       Date:  2013-11-15       Impact factor: 3.575

4.  The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates alpha-synuclein degradation decisions between proteasomal and lysosomal pathways.

Authors:  Youngah Shin; Jochen Klucken; Cam Patterson; Bradley T Hyman; Pamela J McLean
Journal:  J Biol Chem       Date:  2005-04-21       Impact factor: 5.157

5.  Beyond the mitochondrion: cytosolic PINK1 remodels dendrites through protein kinase A.

Authors:  Ruben K Dagda; Irene Pien; Ruth Wang; Jianhui Zhu; Kent Z Q Wang; Jason Callio; Tania Das Banerjee; Raul Y Dagda; Charleen T Chu
Journal:  J Neurochem       Date:  2013-11-13       Impact factor: 5.372

6.  Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability.

Authors:  Alexandra Beilina; Marcel Van Der Brug; Rili Ahmad; Sashi Kesavapany; David W Miller; Gregory A Petsko; Mark R Cookson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-11       Impact factor: 11.205

7.  L347P PINK1 mutant that fails to bind to Hsp90/Cdc37 chaperones is rapidly degraded in a proteasome-dependent manner.

Authors:  Yasuhiro Moriwaki; Yeon-Jeong Kim; Yukari Ido; Hidemi Misawa; Koichiro Kawashima; Shogo Endo; Ryosuke Takahashi
Journal:  Neurosci Res       Date:  2008-01-21       Impact factor: 3.304

8.  CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.

Authors:  Hideki Shimura; Daniel Schwartz; Steven P Gygi; Kenneth S Kosik
Journal:  J Biol Chem       Date:  2003-11-10       Impact factor: 5.157

9.  PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1.

Authors:  Julia W Pridgeon; James A Olzmann; Lih-Shen Chin; Lian Li
Journal:  PLoS Biol       Date:  2007-06-19       Impact factor: 8.029

10.  The PINK1 p.I368N mutation affects protein stability and ubiquitin kinase activity.

Authors:  Maya Ando; Fabienne C Fiesel; Roman Hudec; Thomas R Caulfield; Kotaro Ogaki; Paulina Górka-Skoczylas; Dariusz Koziorowski; Andrzej Friedman; Li Chen; Valina L Dawson; Ted M Dawson; Guojun Bu; Owen A Ross; Zbigniew K Wszolek; Wolfdieter Springer
Journal:  Mol Neurodegener       Date:  2017-04-24       Impact factor: 14.195

View more
  12 in total

1.  PINK1: Multiple mechanisms of neuroprotection.

Authors:  Britney N Lizama; P Anthony Otero; Charleen T Chu
Journal:  Int Rev Mov Disord       Date:  2021-10-04

2.  Chemical Regulation of the Protein Quality Control E3 Ubiquitin Ligase C-Terminus of Hsc70 Interacting Protein (CHIP).

Authors:  Adam J Kanack; Michael D Olp; Oliver J Newsom; Jamie B Scaglione; David M Gooden; Kevin McMahon; Brian C Smith; K Matthew Scaglione
Journal:  Chembiochem       Date:  2022-02-03       Impact factor: 3.461

Review 3.  CHIP as a therapeutic target for neurological diseases.

Authors:  Shuo Zhang; Zheng-Wei Hu; Cheng-Yuan Mao; Chang-He Shi; Yu-Ming Xu
Journal:  Cell Death Dis       Date:  2020-09-09       Impact factor: 8.469

4.  Fbxo7 and Pink1 play a reciprocal role in regulating their protein levels.

Authors:  Tianwen Huang; Lijun Fang; Raoli He; Huidan Weng; Xiaochun Chen; Qinyong Ye; Dianbo Qu
Journal:  Aging (Albany NY)       Date:  2020-12-03       Impact factor: 5.682

5.  CHIP protects against MPP+/MPTP-induced damage by regulating Drp1 in two models of Parkinson's disease.

Authors:  Zhengwei Hu; Chengyuan Mao; Hui Wang; Zhongxian Zhang; Shuo Zhang; Haiyang Luo; Mibo Tang; Jing Yang; Yanpeng Yuan; Yanlin Wang; Yutao Liu; Liyuan Fan; Qimeng Zhang; Dabao Yao; Fen Liu; Jonathan C Schisler; Changhe Shi; Yuming Xu
Journal:  Aging (Albany NY)       Date:  2021-01-02       Impact factor: 5.682

6.  PINK1 Protects against Staurosporine-Induced Apoptosis by Interacting with Beclin1 and Impairing Its Pro-Apoptotic Cleavage.

Authors:  Francesco Brunelli; Liliana Torosantucci; Vania Gelmetti; Davide Franzone; Anne Grünewald; Rejko Krüger; Giuseppe Arena; Enza Maria Valente
Journal:  Cells       Date:  2022-02-15       Impact factor: 7.666

7.  Disrupted structure and aberrant function of CHIP mediates the loss of motor and cognitive function in preclinical models of SCAR16.

Authors:  Chang-He Shi; Carrie Rubel; Sarah E Soss; Rebekah Sanchez-Hodge; Shuo Zhang; Sabrina C Madrigal; Saranya Ravi; Holly McDonough; Richard C Page; Walter J Chazin; Cam Patterson; Cheng-Yuan Mao; Monte S Willis; Hai-Yang Luo; Yu-Sheng Li; Donte A Stevens; Mi-Bo Tang; Pan Du; Yao-He Wang; Zheng-Wei Hu; Yu-Ming Xu; Jonathan C Schisler
Journal:  PLoS Genet       Date:  2018-09-17       Impact factor: 5.917

8.  Human telomerase reverse transcriptase positively regulates mitophagy by inhibiting the processing and cytoplasmic release of mitochondrial PINK1.

Authors:  Woo Hyun Shin; Kwang Chul Chung
Journal:  Cell Death Dis       Date:  2020-06-08       Impact factor: 8.469

9.  Identification of BAG2 and Cathepsin D as Plasma Biomarkers for Parkinson's Disease.

Authors:  Juhee Kang; Jae Whan Kim; Hansol Heo; Jihyun Lee; Kwan Yong Park; Jung Han Yoon; Jaerak Chang
Journal:  Clin Transl Sci       Date:  2020-11-22       Impact factor: 4.689

Review 10.  C-terminus of Hsp70 Interacting Protein (CHIP) and Neurodegeneration: Lessons from the Bench and Bedside.

Authors:  Sivakami Mylvaganam; Rebecca Earnshaw; Gregory Heymann; Suneil K Kalia; Lorraine V Kalia
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.